Activation of the PI3K-AKT Pathway by Old World Alphaviruses

被引:25
|
作者
Van Huizen, Eline [1 ]
McInerney, Gerald M. [1 ]
机构
[1] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden
基金
瑞典研究理事会;
关键词
metabolism; apoptosis; autophagy; SEMLIKI-FOREST-VIRUS; PHOSPHATIDYLINOSITOL; 3-KINASE; GLUCOSE-METABOLISM; SINDBIS VIRUS; AUTOPHAGY; REPLICATION; CELLS; AKT; EXPRESSION; COMPLEXES;
D O I
10.3390/cells9040970
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alphaviruses can infect a broad range of vertebrate hosts, including birds, horses, primates, and humans, in which infection can lead to rash, fever, encephalitis, and arthralgia or arthritis. They are most often transmitted by mosquitoes in which they establish persistent, asymptomatic infections. Currently, there are no vaccines or antiviral therapies for any alphavirus. Several Old World alphaviruses, including Semliki Forest virus, Ross River virus and chikungunya virus, activate or hyperactivate the phosphatidylinositol-3-kinase (PI3K)-AKT pathway in vertebrate cells, potentially influencing many cellular processes, including survival, proliferation, metabolism and autophagy. Inhibition of PI3K or AKT inhibits replication of several alphaviruses either in vitro or in vivo, indicating the importance for viral replication. In this review, we discuss what is known about the mechanism(s) of activation of the pathway during infection and describe those effects of PI3K-AKT activation which could be of advantage to the alphaviruses. Such knowledge may be useful for the identification and development of therapies.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Activation of the PI3K-AKT pathway in human malignant mesothelioma cells
    Suzuki, Yutaro
    Murakami, Hideki
    Kawaguchi, Koji
    Taniguchi, Tetsuo
    Fujii, Makiko
    Shinjo, Keiko
    Kondo, Yutaka
    Osada, Hirotaka
    Shimokata, Kaoru
    Horio, Yoshitsugu
    Hasegawa, Yoshinori
    Hida, Toyoaki
    Sekido, Yoshitaka
    MOLECULAR MEDICINE REPORTS, 2009, 2 (02) : 181 - 188
  • [2] Vortioxetine exhibits anti-glioblastoma activity via the PI3K-Akt signaling pathway
    Zhang, Huan-qi
    Zhang, Dao-ming
    Huang, Zhi-zhen
    Cheng, Jing
    Zhang, Chong
    Lin, Neng-ming
    Li, Yangling
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2025, 28 (04) : 401 - 408
  • [3] The Role of the PI3K-AKT Pathway in Melanoma
    Davies, Michael A.
    CANCER JOURNAL, 2012, 18 (02) : 142 - 147
  • [4] PI3K/Akt pathway activation was involved in acute ethanol-induced fatty liver in mice
    Zeng, Tao
    Zhang, Cui-Li
    Song, Fu-Yong
    Zhao, Xiu-Lan
    Yu, Li-Hua
    Zhu, Zhen-Ping
    Xie, Ke-Qin
    TOXICOLOGY, 2012, 296 (1-3) : 56 - 66
  • [5] Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway
    Saito, Shigeki
    Zhuang, Yan
    Shan, Bin
    Danchuk, Svitlana
    Luo, Fayong
    Korfei, Martina
    Guenther, Andreas
    Lasky, Joseph A.
    PLOS ONE, 2017, 12 (10):
  • [6] INHIBITORS OF PI3K-Akt/PKB-mTOR PATHWAY IN GLIOMA THERAPY
    Jakubowicz-Gil, Joanna
    POSTEPY BIOLOGII KOMORKI, 2009, 36 (02) : 189 - 201
  • [7] Frequent Mutational Activation of the PI3K-AKT Pathway in Trastuzumab-Resistant Breast Cancer
    Chandarlapaty, Sarat
    Sakr, Rita A.
    Giri, Dilip
    Patil, Sujata
    Heguy, Adriana
    Morrow, Monica
    Modi, Shanu
    Norton, Larry
    Rosen, Neal
    Hudis, Clifford
    King, Tari A.
    CLINICAL CANCER RESEARCH, 2012, 18 (24) : 6784 - 6791
  • [8] Targeting the PI3K-Akt pathway in kidney cancer
    Park, Jin-Young
    Lin, Pei-Yin
    Weiss, Robert H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (06) : 863 - 870
  • [9] Mangiferin prevents the growth of gastric carcinoma by blocking the PI3K-Akt signalling pathway
    Du, Min
    Wen, Gang
    Jin, Juan
    Chen, Yuanguang
    Cao, Jun
    Xu, Aman
    ANTI-CANCER DRUGS, 2018, 29 (02) : 167 - 175
  • [10] Neuroprotective Effect of Danhong Injection on Cerebral Ischemia-Reperfusion Injury in Rats by Activation of the PI3K-Akt Pathway
    Feng, Chen
    Wan, Haofang
    Zhang, Yangyang
    Yu, Li
    Shao, Chongyu
    He, Yu
    Wan, Haitong
    Jin, Weifeng
    FRONTIERS IN PHARMACOLOGY, 2020, 11